Home » Topics » BioWorld Science

BioWorld Science
RSS

Atridia initiates phase I study of SHR-1905

Aug. 9, 2021

Signal peptide peptidase-like 2B has a pathogenic role in Alzheimer's disease

Aug. 9, 2021

Enrollment ongoing in phase II study of USB-002 for respiratory distress due to COVID-19

Aug. 9, 2021

Antengene and MindRank AI collaborate to advance difficult-to-drug molecular targets

Aug. 9, 2021

Phase II study of ASC-40 for the treatment of acne vulgaris approved in China

Aug. 9, 2021

Proteins found to promote neuroinflammation in MS

Aug. 9, 2021

Bentrio shows prophylactic and therapeutic effects against influenza A

Aug. 9, 2021

Initial results presented from first-in-human study of ABNCoV2 vaccine

Aug. 9, 2021

AIkido to use machine learning in development of novel broad-spectrum antivirals

Aug. 9, 2021

Targeting synaptogyrin-3 can ameliorate cognitive deficits

Aug. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...